Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)

SHA:603207 Revenue

Shanghai Xiao Fang Pharmaceutical had revenue of 145.69M CNY in the quarter ending March 31, 2026, with 12.88% growth. This brings the company's revenue in the last twelve months to 541.90M, up 13.19% year-over-year. In the year 2025, Shanghai Xiao Fang Pharmaceutical had annual revenue of 525.28M with 10.68% growth.

• Revenue (ttm): 541.90M
• Revenue Growth: +13.19%
• P/S Ratio: 6.59
• Revenue / Employee: 1.02M
• Employees: 529
• Market Cap: 3.57B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	525.28M	50.70M	10.68%
Dec 31, 2024	474.58M	2.71M	0.57%
Dec 31, 2023	471.87M	14.98M	3.28%
Dec 31, 2022	456.89M	55.12M	13.72%
Dec 31, 2021	401.77M	40.54M	11.22%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error